@article{fanucchi_medications_2019,
	title = {Medications for {Treatment} of {Opioid} {Use} {Disorder} among {Persons} {Living} with {HIV}},
	volume = {16},
	issn = {1548-3568, 1548-3576},
	url = {http://link.springer.com/10.1007/s11904-019-00436-7},
	doi = {10.1007/s11904-019-00436-7},
	language = {en},
	number = {1},
	urldate = {2021-03-01},
	journal = {Current HIV/AIDS Reports},
	author = {Fanucchi, Laura and Springer, Sandra A. and Korthuis, P. Todd},
	month = feb,
	year = {2019},
	keywords = {*Buprenorphine, *Extended-release naltrexone, *Medication for opioid use disorder, *Methadone, *Opioid addiction, *Opioid use disorders, *hiv, *mat, Buprenorphine, Buprenorphine/*therapeutic use, Extended-release naltrexone, HIV Infections/drug therapy/etiology, Hiv, Humans, Mat, Medication for opioid use disorder, Methadone, Methadone/*therapeutic use, Naltrexone/*therapeutic use, Opioid addiction, Opioid use disorders, Opioid-Related Disorders/*drug therapy, Treatment Outcome},
	pages = {1--6},
}

{"_id":"WKwJNXnLwH8nYwRww","bibbaseid":"fanucchi-springer-korthuis-medicationsfortreatmentofopioidusedisorderamongpersonslivingwithhiv-2019","author_short":["Fanucchi, L.","Springer, S. A.","Korthuis, P. T."],"bibdata":{"bibtype":"article","type":"article","title":"Medications for Treatment of Opioid Use Disorder among Persons Living with HIV","volume":"16","issn":"1548-3568, 1548-3576","url":"http://link.springer.com/10.1007/s11904-019-00436-7","doi":"10.1007/s11904-019-00436-7","language":"en","number":"1","urldate":"2021-03-01","journal":"Current HIV/AIDS Reports","author":[{"propositions":[],"lastnames":["Fanucchi"],"firstnames":["Laura"],"suffixes":[]},{"propositions":[],"lastnames":["Springer"],"firstnames":["Sandra","A."],"suffixes":[]},{"propositions":[],"lastnames":["Korthuis"],"firstnames":["P.","Todd"],"suffixes":[]}],"month":"February","year":"2019","keywords":"*Buprenorphine, *Extended-release naltrexone, *Medication for opioid use disorder, *Methadone, *Opioid addiction, *Opioid use disorders, *hiv, *mat, Buprenorphine, Buprenorphine/*therapeutic use, Extended-release naltrexone, HIV Infections/drug therapy/etiology, Hiv, Humans, Mat, Medication for opioid use disorder, Methadone, Methadone/*therapeutic use, Naltrexone/*therapeutic use, Opioid addiction, Opioid use disorders, Opioid-Related Disorders/*drug therapy, Treatment Outcome","pages":"1–6","bibtex":"@article{fanucchi_medications_2019,\n\ttitle = {Medications for {Treatment} of {Opioid} {Use} {Disorder} among {Persons} {Living} with {HIV}},\n\tvolume = {16},\n\tissn = {1548-3568, 1548-3576},\n\turl = {http://link.springer.com/10.1007/s11904-019-00436-7},\n\tdoi = {10.1007/s11904-019-00436-7},\n\tlanguage = {en},\n\tnumber = {1},\n\turldate = {2021-03-01},\n\tjournal = {Current HIV/AIDS Reports},\n\tauthor = {Fanucchi, Laura and Springer, Sandra A. and Korthuis, P. Todd},\n\tmonth = feb,\n\tyear = {2019},\n\tkeywords = {*Buprenorphine, *Extended-release naltrexone, *Medication for opioid use disorder, *Methadone, *Opioid addiction, *Opioid use disorders, *hiv, *mat, Buprenorphine, Buprenorphine/*therapeutic use, Extended-release naltrexone, HIV Infections/drug therapy/etiology, Hiv, Humans, Mat, Medication for opioid use disorder, Methadone, Methadone/*therapeutic use, Naltrexone/*therapeutic use, Opioid addiction, Opioid use disorders, Opioid-Related Disorders/*drug therapy, Treatment Outcome},\n\tpages = {1--6},\n}\n\n","author_short":["Fanucchi, L.","Springer, S. A.","Korthuis, P. T."],"key":"fanucchi_medications_2019","id":"fanucchi_medications_2019","bibbaseid":"fanucchi-springer-korthuis-medicationsfortreatmentofopioidusedisorderamongpersonslivingwithhiv-2019","role":"author","urls":{"Paper":"http://link.springer.com/10.1007/s11904-019-00436-7"},"keyword":["*Buprenorphine","*Extended-release naltrexone","*Medication for opioid use disorder","*Methadone","*Opioid addiction","*Opioid use disorders","*hiv","*mat","Buprenorphine","Buprenorphine/*therapeutic use","Extended-release naltrexone","HIV Infections/drug therapy/etiology","Hiv","Humans","Mat","Medication for opioid use disorder","Methadone","Methadone/*therapeutic use","Naltrexone/*therapeutic use","Opioid addiction","Opioid use disorders","Opioid-Related Disorders/*drug therapy","Treatment Outcome"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero-group/Sierramatice/2808357","dataSources":["hF4cB9z6ogae2WwKD","wPp9MbcfArPrcn3De","3wdaKc5dBzq6bPRq5"],"keywords":["*buprenorphine","*extended-release naltrexone","*medication for opioid use disorder","*methadone","*opioid addiction","*opioid use disorders","*hiv","*mat","buprenorphine","buprenorphine/*therapeutic use","extended-release naltrexone","hiv infections/drug therapy/etiology","hiv","humans","mat","medication for opioid use disorder","methadone","methadone/*therapeutic use","naltrexone/*therapeutic use","opioid addiction","opioid use disorders","opioid-related disorders/*drug therapy","treatment outcome"],"search_terms":["medications","treatment","opioid","use","disorder","persons","living","hiv","fanucchi","springer","korthuis"],"title":"Medications for Treatment of Opioid Use Disorder among Persons Living with HIV","year":2019}